| Year |
Citation |
Score |
| 2024 |
Gardner RA, Ferkol TW, Davis SD, Rosenfeld M, Sagel SD, Dell SD, Milla CE, Li L, Lin FC, Sullivan KM, Zariwala MA, Knowles MR, Leigh MW. Therapies Used by Children With Primary Ciliary Dyskinesia: A Natural History Study. Pediatric Pulmonology. e27412. PMID 39575633 DOI: 10.1002/ppul.27412 |
0.455 |
|
| 2024 |
Kinghorn B, Rosenfeld M, Sullivan E, Onchiri FM, Brown MD, Szczesniak R, Ferkol TW, Sagel SD, Dell SD, Milla C, Shapiro AJ, Sullivan KM, Zariwala MA, Pittman JE, Knowles MR, et al. Comparison of Longitudinal Outcomes in Children with Primary Ciliary Dyskinesia and Cystic Fibrosis. Annals of the American Thoracic Society. PMID 39383539 DOI: 10.1513/AnnalsATS.202311-1008OC |
0.581 |
|
| 2023 |
Kaspy KR, Dell SD, Davis SD, Ferkol TW, Rosenfeld M, Sagel SD, Milla C, Olivier KN, Barber AT, Wee W, Lin FC, Li L, Rampakakis E, Zariwala MA, Knowles MR, et al. Situs ambiguus is associated with adverse clinical outcomes in children with primary ciliary dyskinesia. Chest. PMID 38072392 DOI: 10.1016/j.chest.2023.12.005 |
0.47 |
|
| 2023 |
Sanders DB, Bartz TM, Zemanick ET, Hoppe JE, Hinckley Stukovsky KD, Cogen JD, Bendy L, McNamara S, Enright E, Kime NA, Kronmal RA, Edwards TC, Morgan WJ, Rosenfeld M. A Pilot Randomized Trial of Pediatric Cystic Fibrosis Pulmonary Exacerbations Treatment Strategies. Annals of the American Thoracic Society. PMID 37683122 DOI: 10.1513/AnnalsATS.202303-245OC |
0.326 |
|
| 2023 |
DeBoer EM, Morgan WJ, Quiros-Alcala L, Rosenfeld M, Stout JW, Davis SD, Gaffin JM. Defining and Promoting Pediatric Pulmonary Health: Assessing Lung Function and Structure. Pediatrics. 152. PMID 37656029 DOI: 10.1542/peds.2023-062292E |
0.518 |
|
| 2023 |
Chen Y, Lv Q, Andrinopoulou ER, Gallardo-Estrella L, Charbonnier JP, Caudri D, Davis SD, Rosenfeld M, Ratjen F, Kronmal RA, Stukovsky KDH, Stick S, Tiddens HAWM. Automatic bronchus and artery analysis on chest computed tomography to evaluate the effect of inhaled hypertonic saline in children aged 3-6 years with cystic fibrosis in a randomized clinical trial. Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society. PMID 37246053 DOI: 10.1016/j.jcf.2023.05.013 |
0.525 |
|
| 2023 |
Goralski JL, Hoppe JE, Mall MA, McColley SA, McKone E, Ramsey B, Rayment JH, Robinson P, Stehling F, Taylor-Cousar JL, Tullis E, Ahluwalia N, Chin A, Chu C, Lu M, ... ... Rosenfeld M, et al. Phase 3 Open-Label Clinical Trial of Elexacaftor/Tezacaftor/Ivacaftor in Children Aged 2 Through 5 Years with Cystic Fibrosis and at Least One Allele. American Journal of Respiratory and Critical Care Medicine. PMID 36921081 DOI: 10.1164/rccm.202301-0084OC |
0.317 |
|
| 2022 |
Kinghorn B, Rosenfeld M, Sullivan E, Onchiri F, Ferkol TW, Sagel SD, Dell SD, Milla C, Shapiro AJ, Sullivan KM, Zariwala MA, Pittman JE, Mollica F, Tiddens HAWM, Kemner-van de Corput M, et al. Airway Disease in Children with Primary Ciliary Dyskinesia: Impact of Ciliary Ultrastructure Defect and Genotype. Annals of the American Thoracic Society. PMID 36442147 DOI: 10.1513/AnnalsATS.202206-524OC |
0.526 |
|
| 2022 |
Barber AT, Shapiro AJ, Davis SD, Ferkol TW, Atkinson JJ, Sagel SD, Dell SD, Olivier KN, Milla CE, Rosenfeld M, Li L, Lin FC, Sullivan KM, Capps NA, Zariwala MA, et al. Laterality Defects in Primary Ciliary Dyskinesia: Relationship to Ultrastructural Defect or Genotype. Annals of the American Thoracic Society. PMID 36342963 DOI: 10.1513/AnnalsATS.202206-487OC |
0.414 |
|
| 2022 |
Davis CS, Faino AV, Onchiri F, Gibson RL, Merjaneh L, Ramsey BW, Rosenfeld M, Cogen JD. Systemic Corticosteroids in the Management of Pediatric Cystic Fibrosis Pulmonary Exacerbations. Annals of the American Thoracic Society. PMID 36044723 DOI: 10.1513/AnnalsATS.202203-201OC |
0.316 |
|
| 2022 |
Sagel SD, Kupfer O, Wagner BD, Davis SD, Dell SD, Ferkol TW, Hoppe JE, Rosenfeld M, Sullivan KM, Tiddens HAWM, Knowles MR, Leigh MW. Airway Inflammation in Children with Primary Ciliary Dyskinesia. Annals of the American Thoracic Society. PMID 35984413 DOI: 10.1513/AnnalsATS.202204-314OC |
0.494 |
|
| 2022 |
Wee WB, Leigh MW, Davis SD, Rosenfeld M, Sullivan KM, Sawras MG, Ferkol TW, Knowles MR, Milla C, Sagel SD, Zariwala MA, Pullenayegum E, Dell SD. Association of Neonatal Hospital Length of Stay with Lung Function in Primary Ciliary Dyskinesia. Annals of the American Thoracic Society. PMID 35657736 DOI: 10.1513/AnnalsATS.202202-116OC |
0.525 |
|
| 2022 |
Zhai J, Emond MJ, Spangenberg A, Stern DA, Vasquez MM, Blue EE, Buckingham KJ, Sherrill DL, Halonen M, Gibson RL, Rosenfeld M, Sagel SD, Bamshad MJ, Morgan WJ, Guerra S. Club cell secretory protein and lung function in children with cystic fibrosis. Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society. PMID 35367162 DOI: 10.1016/j.jcf.2022.03.007 |
0.316 |
|
| 2022 |
Cogen JD, Faino AV, Onchiri F, Gibson RL, Hoffman LR, Nichols DP, Rosenfeld M, Kronman MP. Clinical Outcomes of Antipseudomonal versus Other Antibiotics Among Children with Cystic Fibrosis without . Annals of the American Thoracic Society. PMID 35289740 DOI: 10.1513/AnnalsATS.202111-1294OC |
0.306 |
|
| 2022 |
Tiddens HAWM, Chen Y, Andrinopoulou ER, Davis SD, Rosenfeld M, Ratjen F, Kronmal RA, Hinckley Stukovsky KD, Dasiewicz A, Stick SM. The effect of inhaled hypertonic saline on lung structure in children aged 3-6 years with cystic fibrosis (SHIP-CT): a multicentre, randomised, double-blind, controlled trial. The Lancet. Respiratory Medicine. PMID 35286860 DOI: 10.1016/S2213-2600(21)00546-4 |
0.564 |
|
| 2021 |
Cogen JD, Faino AV, Onchiri F, Hoffman LR, Kronman MP, Nichols DP, Rosenfeld M, Gibson RL. Association Between Number of Intravenous Antipseudomonal Antibiotics and Clinical Outcomes of Pediatric Cystic Fibrosis Pulmonary Exacerbations. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 34100912 DOI: 10.1093/cid/ciab525 |
0.305 |
|
| 2020 |
Taylor JB, Oermann CM, Deterding RR, Redding G, Davis SD, Piccione J, Moore PE, Kupfer O, Santiago MT, Rosenfeld M, Ingram DG, Ross K, DeBoer EM. Innovating and Adapting in Pediatric Pulmonology and Sleep Medicine During the COVID-19 Pandemic: ATS Pediatric Assembly Web Committee Consensus Statement for Initial COVID-19 Virtual Response. Pediatric Pulmonology. PMID 33300286 DOI: 10.1002/ppul.25218 |
0.429 |
|
| 2020 |
Davies JC, Wainwright CE, Sawicki GS, Higgins MN, Campbell D, Harris C, Panorchan P, Haseltine E, Tian S, Rosenfeld M. Ivacaftor in Infants Aged 4 to <12 Months With Cystic Fibrosis and a Gating Mutation: Results of a 2-Part Phase 3 Clinical Trial. American Journal of Respiratory and Critical Care Medicine. PMID 33023304 DOI: 10.1164/rccm.202008-3177OC |
0.309 |
|
| 2020 |
Hoppe JE, Hinds DM, Colborg A, Wagner BD, Morgan WJ, Rosenfeld M, Zemanick ET, Sanders DB. Oral antibiotic prescribing patterns for treatment of pulmonary exacerbations in two large pediatric CF centers. Pediatric Pulmonology. PMID 32970375 DOI: 10.1002/ppul.25092 |
0.326 |
|
| 2020 |
Cogen JD, Faino AV, Onchiri F, Gibson RL, Hoffman LR, Kronman MP, Rosenfeld M, Nichols DP. Effect of Concomitant Azithromycin and Tobramycin Use on Cystic Fibrosis Pulmonary Exacerbation Treatment. Annals of the American Thoracic Society. PMID 32810412 DOI: 10.1513/Annalsats.202002-176Oc |
0.416 |
|
| 2020 |
Cogen JD, Faino AV, Onchiri F, Hoffman LR, Kronman MP, Nelson M, Nichols DP, Rosenfeld M, VanDevanter DR, Gibson RL. Association of Inhaled Antibiotics in Addition to Standard IV Therapy and Outcomes of Pediatric Inpatient Pulmonary Exacerbations. Annals of the American Thoracic Society. PMID 32726564 DOI: 10.1513/Annalsats.202002-179Oc |
0.431 |
|
| 2020 |
Kinghorn B, McNamara S, Genatossio A, Sullivan E, Siegel M, Bauer I, Clem C, Johnson RC, Davis M, Griffiths A, Wheeler W, Johnson K, Davis SD, Leigh MW, Rosenfeld M, et al. Comparison of Multiple Breath Washout and Spirometry in Children with Primary Ciliary Dyskinesia and Cystic Fibrosis and Healthy Controls. Annals of the American Thoracic Society. PMID 32603187 DOI: 10.1513/Annalsats.201905-375Oc |
0.633 |
|
| 2019 |
Toprak D, Nay L, McNamara S, Rosenberg AR, Rosenfeld M, Yi-Frazier JP. Resilience in adolescents and young adults with cystic fibrosis: A pilot feasibility study of the promoting resilience in stress management intervention. Pediatric Pulmonology. PMID 31794160 DOI: 10.1002/Ppul.24574 |
0.311 |
|
| 2019 |
Suthoff E, Mainz JG, Cox DW, Thorat T, Grossoehme DH, Fridman M, Sawicki GS, Rosenfeld M. Caregiver Burden Due to Pulmonary Exacerbations in Patients with Cystic Fibrosis. The Journal of Pediatrics. 215: 164-171.e2. PMID 31761140 DOI: 10.1016/J.Jpeds.2019.08.038 |
0.459 |
|
| 2019 |
Toprak D, Davis C, Rosenfeld M. Treating the Airway Consequences of Cystic Fibrosis Transmembrane Conductance Regulator Dysfunction. Seminars in Respiratory and Critical Care Medicine. PMID 31659732 DOI: 10.1055/S-0039-1698462 |
0.439 |
|
| 2019 |
Graham BL, Steenbruggen I, Miller MR, Barjaktarevic IZ, Cooper BG, Hall GL, Hallstrand TS, Kaminsky DA, McCarthy K, McCormack MC, Oropez CE, Rosenfeld M, Stanojevic S, Swanney MP, Thompson BR. Standardization of Spirometry 2019 Update. An Official American Thoracic Society and European Respiratory Society Technical Statement. American Journal of Respiratory and Critical Care Medicine. 200: e70-e88. PMID 31613151 DOI: 10.1164/Rccm.201908-1590St |
0.356 |
|
| 2019 |
Sanders DB, Ostrenga JS, Rosenfeld M, Fink AK, Schechter MS, Sawicki GS, Flume PA, Morgan WJ. Predictors of pulmonary exacerbation treatment in cystic fibrosis. Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society. PMID 31257102 DOI: 10.1016/J.Jcf.2019.06.008 |
0.446 |
|
| 2019 |
Fink AK, Graff G, Byington CL, Loeffler DR, Rosenfeld M, Saiman L. Palivizumab and Long-term Outcomes in Cystic Fibrosis. Pediatrics. PMID 31239289 DOI: 10.1542/Peds.2018-3495 |
0.421 |
|
| 2019 |
Ratjen F, Davis SD, Stanojevic S, Kronmal RA, Hinckley Stukovsky KD, Jorgensen N, Rosenfeld M. Inhaled hypertonic saline in preschool children with cystic fibrosis (SHIP): a multicentre, randomised, double-blind, placebo-controlled trial. The Lancet. Respiratory Medicine. PMID 31178421 DOI: 10.1016/S2213-2600(19)30187-0 |
0.631 |
|
| 2019 |
Rosenfeld M, Cunningham S, Harris WT, Lapey A, Regelmann WE, Sawicki GS, Southern KW, Chilvers M, Higgins M, Tian S, Cooke J, Davies JC. An open-label extension study of ivacaftor in children with CF and a CFTR gating mutation initiating treatment at age 2-5 years (KLIMB). Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society. PMID 31053538 DOI: 10.1016/J.Jcf.2019.03.009 |
0.414 |
|
| 2019 |
Szczesniak RD, Cogen JD, Rosenfeld M. Associating antimicrobial susceptibility testing with clinical outcomes in cystic fibrosis: More rigor and less frequency? Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society. PMID 30824378 DOI: 10.1016/J.Jcf.2019.02.008 |
0.336 |
|
| 2019 |
Juarez-Colunga E, Rosenfeld M, Zemanick ET, Wagner B. Application of multiple event analysis as an alternative approach to studying pulmonary exacerbations as an outcome measure. Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society. PMID 30642785 DOI: 10.1016/J.Jcf.2018.12.005 |
0.4 |
|
| 2019 |
Hurley M, McKeever T, Fogarty A, Goss C, Rosenfeld M, Smyth A. P109 Antistaphylococcal antibiotic prophylaxis usage among infants with cystic fibrosis in the UK Journal of Cystic Fibrosis. 18. DOI: 10.1016/S1569-1993(19)30403-5 |
0.348 |
|
| 2019 |
Davies J, Wang L, Panorchan P, Campbell D, Tian S, Higgins M, Egbuna O, McKee C, Rosenfeld M. WS06-4 Ivacaftor (IVA) treatment in patients 6 to <12 months old with cystic fibrosis with a CFTR gating mutation: results of a 2-part, single-arm, phase 3 study Journal of Cystic Fibrosis. 18: S11. DOI: 10.1016/S1569-1993(19)30151-1 |
0.359 |
|
| 2018 |
Davis SD, Rosenfeld M, Lee HS, Ferkol TW, Sagel SD, Dell SD, Milla C, Pittman JE, Shapiro AJ, Sullivan KM, Nykamp KR, Krischer JP, Zariwala MA, Knowles MR, Leigh MW, et al. Primary Ciliary Dyskinesia: Longitudinal Study of Lung Disease by Ultrastructure Defect and Genotype. American Journal of Respiratory and Critical Care Medicine. PMID 30067075 DOI: 10.1164/Rccm.201803-0548Oc |
0.55 |
|
| 2018 |
Chi DL, Rosenfeld M, Mancl L, Chung WO, Presland RB, Sarvas E, Rothen M, Alkhateeb A, McNamara S, Genatossio A, Virella-Lowell I, Milla C, Scott J. Age-related heterogeneity in dental caries and associated risk factors in individuals with cystic fibrosis ages 6-20 years: A pilot study. Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society. PMID 30005828 DOI: 10.1016/J.Jcf.2018.06.009 |
0.36 |
|
| 2018 |
Shapiro AJ, Davis SD, Polineni D, Manion M, Rosenfeld M, Dell SD, Chilvers MA, Ferkol TW, Zariwala MA, Sagel SD, Josephson M, Morgan L, Yilmaz O, Olivier KN, Milla C, et al. Diagnosis of Primary Ciliary Dyskinesia. An Official American Thoracic Society Clinical Practice Guideline. American Journal of Respiratory and Critical Care Medicine. 197: e24-e39. PMID 29905515 DOI: 10.1164/Rccm.201805-0819St |
0.485 |
|
| 2018 |
Mayer-Hamblett N, Retsch-Bogart G, Kloster M, Accurso F, Rosenfeld M, Albers G, Black P, Brown P, Cairns A, Davis SD, Graff GR, Kerby GS, Orenstein D, Buckingham R, Ramsey BW, et al. Azithromycin for Early Pseudomonas Infection in Cystic Fibrosis: The Optimize Randomized Trial. American Journal of Respiratory and Critical Care Medicine. PMID 29890086 DOI: 10.1164/Rccm.201802-0215Oc |
0.553 |
|
| 2018 |
Rosenfeld M, Wainwright CE, Higgins M, Wang LT, McKee C, Campbell D, Tian S, Schneider J, Cunningham S, Davies JC. Ivacaftor treatment of cystic fibrosis in children aged 12 to <24 months and with a CFTR gating mutation (ARRIVAL): a phase 3 single-arm study. The Lancet. Respiratory Medicine. PMID 29886024 DOI: 10.1016/S2213-2600(18)30202-9 |
0.404 |
|
| 2018 |
Ratjen F, Klingel M, Black P, Powers MR, Grasemann H, Solomon M, Sagel SD, Donaldson SH, Rowe SM, Rosenfeld M. Changes in Lung Clearance Index in Preschool Cystic Fibrosis Patients Treated with Ivacaftor. American Journal of Respiratory and Critical Care Medicine. PMID 29614238 DOI: 10.1164/Rccm.201802-0243Le |
0.413 |
|
| 2018 |
Robinson PD, Latzin P, Ramsey KA, Stanojevic S, Aurora P, Davis SD, Gappa M, Hall GL, Horsley A, Jensen R, Lum S, Milla C, Nielsen KG, Pittman JE, Rosenfeld M, et al. Preschool Multiple-Breath Washout Testing. An Official American Thoracic Society Technical Statement. American Journal of Respiratory and Critical Care Medicine. 197: e1-e19. PMID 29493315 DOI: 10.1164/Rccm.201801-0074St |
0.582 |
|
| 2018 |
Cogen JD, Onchiri F, Emerson J, Gibson RL, Hoffman LR, Nichols DP, Rosenfeld M. Chronic Azithromycin Use in Cystic Fibrosis and Risk of Treatment-Emergent Respiratory Pathogens. Annals of the American Thoracic Society. PMID 29474110 DOI: 10.1513/Annalsats.201801-012Oc |
0.433 |
|
| 2018 |
Cogen JD, Rosenfeld M. Treating Cystic Fibrosis Pulmonary Exacerbations: In the Hospital with a Physician or at Home under Your Own Supervision? Annals of the American Thoracic Society. 15: 169-170. PMID 29388818 DOI: 10.1513/Annalsats.201711-891Ed |
0.364 |
|
| 2018 |
Edwards TC, Emerson J, Genatossio A, McNamara S, Goss C, Patrick DL, Onchiri F, Rosenfeld M. Initial development and pilot testing of observer-reported outcomes (ObsROs) for children with cystic fibrosis ages 0-11years. Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society. PMID 29358075 DOI: 10.1016/J.Jcf.2017.12.008 |
0.41 |
|
| 2017 |
Sawicki GS, Ostrenga J, Petren K, Fink AK, D'Agostino E, Strassle C, Schechter MS, Rosenfeld M. Risk Factors for Gaps in Care during Transfer from Pediatric to Adult Cystic Fibrosis Programs in the United States. Annals of the American Thoracic Society. PMID 29220199 DOI: 10.1513/Annalsats.201705-357Oc |
0.323 |
|
| 2017 |
Culver BH, Graham BL, Coates AL, Wanger J, Berry CE, Clarke PK, Hallstrand TS, Hankinson JL, Kaminsky DA, MacIntyre NR, McCormack MC, Rosenfeld M, Stanojevic S, Weiner DJ. Recommendations for a Standardized Pulmonary Function Report. An Official American Thoracic Society Technical Statement. American Journal of Respiratory and Critical Care Medicine. 196: 1463-1472. PMID 29192835 DOI: 10.1164/Rccm.201710-1981St |
0.344 |
|
| 2017 |
Rosenfeld M, Ostrowski LE, Zariwala MA. Primary ciliary dyskinesia: keep it on your radar. Thorax. PMID 29133352 DOI: 10.1136/Thoraxjnl-2017-210776 |
0.346 |
|
| 2017 |
Heltshe SL, Khan U, Beckett V, Baines A, Emerson J, Sanders DB, Gibson RL, Morgan W, Rosenfeld M. Longitudinal development of initial, chronic and mucoid Pseudomonas aeruginosa infection in young children with cystic fibrosis. Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society. PMID 29110966 DOI: 10.1016/J.Jcf.2017.10.008 |
0.396 |
|
| 2017 |
Psoter KJ, De Roos AJ, Wakefield J, Mayer JD, Rosenfeld M. Air pollution exposure is associated with MRSA acquisition in young U.S. children with cystic fibrosis. Bmc Pulmonary Medicine. 17: 106. PMID 28750627 DOI: 10.1186/S12890-017-0449-8 |
0.397 |
|
| 2017 |
Psoter KJ, De Roos AJ, Wakefield J, Mayer JD, Rosenfeld M. Seasonality of acquisition of respiratory bacterial pathogens in young children with cystic fibrosis. Bmc Infectious Diseases. 17: 411. PMID 28599639 DOI: 10.1186/S12879-017-2511-9 |
0.425 |
|
| 2017 |
Shapiro AJ, Josephson M, Rosenfeld M, Yilmaz O, Davis SD, Polineni D, Guadagno E, Leigh MW, Lavergne V. Accuracy of Nasal Nitric Oxide Measurement as a Diagnostic Test for Primary Ciliary Dyskinesia: A Systematic Review and Meta-Analysis. Annals of the American Thoracic Society. PMID 28481653 DOI: 10.1513/Annalsats.201701-062Sr |
0.539 |
|
| 2017 |
Pittman J, Rosenfeld M. Elementary, My Dear Watson! The Accumulating Evidence for the Lung Clearance Index in Monitoring Early Cystic Fibrosis Lung Disease. American Journal of Respiratory and Critical Care Medicine. 195: 1131-1132. PMID 28459345 DOI: 10.1164/Rccm.201701-0025Ed |
0.407 |
|
| 2017 |
Smyth AR, Rosenfeld M. Prophylactic anti-staphylococcal antibiotics for cystic fibrosis. The Cochrane Database of Systematic Reviews. 4: CD001912. PMID 28417451 DOI: 10.1002/14651858.Cd001912.Pub4 |
0.39 |
|
| 2017 |
Farrell PM, White TB, Ren CL, Hempstead SE, Accurso F, Derichs N, Howenstine M, McColley SA, Rock M, Rosenfeld M, Sermet-Gaudelus I, Southern KW, Marshall BC, Sosnay PR. Diagnosis of Cystic Fibrosis: Consensus Guidelines from the Cystic Fibrosis Foundation. The Journal of Pediatrics. 181: S4-S15.e1. PMID 28129811 DOI: 10.1016/J.Jpeds.2016.09.064 |
0.433 |
|
| 2017 |
Farrell PM, White TB, Howenstine MS, Munck A, Parad RB, Rosenfeld M, Sommerburg O, Accurso FJ, Davies JC, Rock MJ, Sanders DB, Wilschanski M, Sermet-Gaudelus I, Blau H, Gartner S, et al. Diagnosis of Cystic Fibrosis in Screened Populations. The Journal of Pediatrics. 181: S33-S44.e2. PMID 28129810 DOI: 10.1016/J.Jpeds.2016.09.065 |
0.629 |
|
| 2017 |
Cogen JD, Oron AP, Gibson RL, Hoffman LR, Kronman MP, Ong T, Rosenfeld M. Characterization of Inpatient Cystic Fibrosis Pulmonary Exacerbations. Pediatrics. PMID 28126911 DOI: 10.1542/Peds.2016-2642 |
0.439 |
|
| 2017 |
Ong T, Schechter M, Yang J, Peng L, Emerson J, Gibson RL, Morgan W, Rosenfeld M. Socioeconomic Status, Smoke Exposure, and Health Outcomes in Young Children With Cystic Fibrosis. Pediatrics. PMID 28093464 DOI: 10.1542/Peds.2016-2730 |
0.358 |
|
| 2017 |
Klingel M, Stanojevic S, Jensen R, Rosenfeld M, Davis S, Ratjen F, Retsch-Bogart G. Effect of reporting two versus three trials on lung clearance index values European Respiratory Journal. DOI: 10.1183/1393003.Congress-2017.Oa1792 |
0.538 |
|
| 2017 |
Chilvers M, Tian S, Marigowda G, Bsharat M, Hug C, Solomon M, Black P, Rosenfeld M, Sawicki G, Hoppe J. S96 An open-label extension (ext) study of lumacaftor/ivacaftor (lum/iva) therapy in patients aged 6 to 11 years with cystic fibrosis (cf) homozygous for f508del-cftr Thorax. 72. DOI: 10.1136/Thoraxjnl-2017-210983.102 |
0.392 |
|
| 2017 |
Chilvers M, Tian S, Marigowda G, Bsharat M, Hug C, Solomon M, Black P, Rosenfeld M, Sawicki G, Hoppe J. 52 An open-label extension (EXT) study of lumacaftor/ivacaftor (LUM/IVA) therapy in patients (pts) aged 6–11 years (yrs) with cystic fibrosis (CF) homozygous for F508del-CFTR Journal of Cystic Fibrosis. 16: S77. DOI: 10.1016/S1569-1993(17)30417-4 |
0.384 |
|
| 2016 |
Milla CE, Ratjen F, Marigowda G, Liu F, Waltz D, Rosenfeld M. Lumacaftor/Ivacaftor in Patients Aged 6-11 Years With Cystic Fibrosis Homozygous for F508del-CFTR. American Journal of Respiratory and Critical Care Medicine. PMID 27805836 DOI: 10.1164/Rccm.201608-1754Oc |
0.42 |
|
| 2016 |
Rosenfeld M, Sontag MK, Ren CL. Cystic Fibrosis Diagnosis and Newborn Screening. Pediatric Clinics of North America. 63: 599-615. PMID 27469178 DOI: 10.1016/J.Pcl.2016.04.004 |
0.394 |
|
| 2016 |
Leigh MW, Ferkol TW, Davis SD, Lee HS, Rosenfeld M, Dell SD, Sagel SD, Milla C, Olivier KN, Sullivan KM, Zariwala MA, Pittman J, Shapiro AJ, Carson JL, Krischer J, et al. Clinical Features and Associated Likelihood of Primary Ciliary Dyskinesia in Children and Adolescents. Annals of the American Thoracic Society. PMID 27070726 DOI: 10.1513/Annalsats.201511-748Oc |
0.53 |
|
| 2016 |
Lahiri T, Hempstead SE, Brady C, Cannon CL, Clark K, Condren ME, Guill MF, Guillerman RP, Leone CG, Maguiness K, Monchil L, Powers SW, Rosenfeld M, Schwarzenberg SJ, Tompkins CL, et al. Clinical Practice Guidelines From the Cystic Fibrosis Foundation for Preschoolers With Cystic Fibrosis. Pediatrics. PMID 27009033 DOI: 10.1542/Peds.2015-1784 |
0.612 |
|
| 2016 |
Peterson-Carmichael S, Seddon PC, Cheifetz IM, Frerichs I, Hall GL, Hammer J, Hantos Z, van Kaam AH, McEvoy CT, Newth CJ, Pillow JJ, Rafferty GF, Rosenfeld M, Stocks J, Ranganathan SC, et al. An Official American Thoracic Society/European Respiratory Society Workshop Report: Evaluation of Respiratory Mechanics and Function in the Pediatric and Neonatal Intensive Care Units. Annals of the American Thoracic Society. 13: S1-S11. PMID 26848609 DOI: 10.1513/Annalsats.201511-730St |
0.394 |
|
| 2016 |
Davies JC, Cunningham S, Harris WT, Lapey A, Regelmann WE, Sawicki GS, Southern KW, Robertson S, Green Y, Cooke J, Rosenfeld M. Safety, pharmacokinetics, and pharmacodynamics of ivacaftor in patients aged 2-5 years with cystic fibrosis and a CFTR gating mutation (KIWI): an open-label, single-arm study. The Lancet. Respiratory Medicine. PMID 26803277 DOI: 10.1016/S2213-2600(15)00545-7 |
0.375 |
|
| 2016 |
Davies J, Robertson S, Cooke J, Higgins M, Rosenfeld M. S112 Long-term safety and efficacy of ivacaftor in paediatric patients aged 2–5 years with cystic fibrosis and a CFTR gating mutation Thorax. 71: A67.1-A67. DOI: 10.1136/Thoraxjnl-2016-209333.118 |
0.34 |
|
| 2016 |
Chi DL, Rosenfeld M, Sarvas E, Mcnamara S, Genatossio A, Rothen M, Kim A. 269 Tooth decay risk factors for individuals with cystic fibrosis Journal of Cystic Fibrosis. 15. DOI: 10.1016/S1569-1993(16)30507-0 |
0.303 |
|
| 2015 |
Davis SD, Ratjen F, Brumback LC, Johnson RC, Filbrun AG, Kerby GS, Panitch HB, Donaldson SH, Rosenfeld M. Infant lung function tests as endpoints in the ISIS multicenter clinical trial in cystic fibrosis. Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society. PMID 26547590 DOI: 10.1016/J.Jcf.2015.10.007 |
0.585 |
|
| 2015 |
Psoter KJ, DE Roos AJ, Wakefield J, Mayer JD, Bryan M, Rosenfeld M. Association of meteorological and geographical factors and risk of initial Pseudomonas aeruginosa acquisition in young children with cystic fibrosis. Epidemiology and Infection. 1-9. PMID 26449886 DOI: 10.1017/S0950268815002411 |
0.313 |
|
| 2015 |
Shapiro AJ, Zariwala MA, Ferkol T, Davis SD, Sagel SD, Dell SD, Rosenfeld M, Olivier KN, Milla C, Daniel SJ, Kimple AJ, Manion M, Knowles MR, Leigh MW. Diagnosis, monitoring, and treatment of primary ciliary dyskinesia: PCD foundation consensus recommendations based on state of the art review. Pediatric Pulmonology. PMID 26418604 DOI: 10.1002/Ppul.23304 |
0.585 |
|
| 2015 |
Sanders DB, Fink A, Mayer-Hamblett N, Schechter MS, Sawicki GS, Rosenfeld M, Flume PA, Morgan WJ. Early Life Growth Trajectories in Cystic Fibrosis are Associated with Pulmonary Function at Age 6 Years. The Journal of Pediatrics. PMID 26340874 DOI: 10.1016/J.Jpeds.2015.07.044 |
0.453 |
|
| 2015 |
Sanders DB, Emerson J, Ren CL, Schechter MS, Gibson RL, Morgan W, Rosenfeld M. Early Childhood Risk Factors for Decreased FEV1 at Age Six to Seven Years in Young Children with Cystic Fibrosis. Annals of the American Thoracic Society. 12: 1170-6. PMID 26288390 DOI: 10.1513/Annalsats.201504-198Oc |
0.462 |
|
| 2015 |
Rosenfeld M, VanDevanter DR, Ren CL, Elkin EP, Pasta DJ, Konstan MW, Morgan WJ. Decline in lung function does not predict future decline in lung function in cystic fibrosis patients. Pediatric Pulmonology. PMID 26086901 DOI: 10.1002/Ppul.23227 |
0.404 |
|
| 2015 |
Subbarao P, Milla C, Aurora P, Davies JC, Davis SD, Hall GL, Heltshe S, Latzin P, Lindblad A, Pittman JE, Robinson PD, Rosenfeld M, Singer F, Starner TD, Ratjen F, et al. Multiple-Breath Washout as a Lung Function Test in Cystic Fibrosis. A Cystic Fibrosis Foundation Workshop Report. Annals of the American Thoracic Society. 12: 932-9. PMID 26075554 DOI: 10.1513/Annalsats.201501-021Fr |
0.644 |
|
| 2015 |
Cogen J, Emerson J, Sanders DB, Ren C, Schechter MS, Gibson RL, Morgan W, Rosenfeld M. Risk factors for lung function decline in a large cohort of young cystic fibrosis patients. Pediatric Pulmonology. 50: 763-70. PMID 26061914 DOI: 10.1002/Ppul.23217 |
0.377 |
|
| 2015 |
Mayer-Hamblett N, Kloster M, Rosenfeld M, Gibson RL, Retsch-Bogart GZ, Emerson J, Thompson V, Ramsey BW. Impact of Sustained Eradication of New Pseudomonas aeruginosa Infection on Long-term Outcomes in Cystic Fibrosis. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 25972024 DOI: 10.1093/Cid/Civ377 |
0.351 |
|
| 2015 |
Ren CL, Fink AK, Petren K, Borowitz DS, McColley SA, Sanders DB, Rosenfeld M, Marshall BC. Outcomes of infants with indeterminate diagnosis detected by cystic fibrosis newborn screening. Pediatrics. 135: e1386-92. PMID 25963008 DOI: 10.1542/Peds.2014-3698 |
0.407 |
|
| 2015 |
Psoter KJ, De Roos AJ, Mayer JD, Kaufman JD, Wakefield J, Rosenfeld M. Fine particulate matter exposure and initial Pseudomonas aeruginosa acquisition in cystic fibrosis. Annals of the American Thoracic Society. 12: 385-91. PMID 25594356 DOI: 10.1513/Annalsats.201408-400Oc |
0.398 |
|
| 2015 |
Schechter MS, Regelmann WE, Sawicki GS, Rasouliyan L, VanDevanter DR, Rosenfeld M, Pasta D, Morgan W, Konstan MW. Antibiotic treatment of signs and symptoms of pulmonary exacerbations: a comparison by care site. Pediatric Pulmonology. 50: 431-40. PMID 25530325 DOI: 10.1002/Ppul.23147 |
0.377 |
|
| 2015 |
Davis SD, Ferkol TW, Rosenfeld M, Lee HS, Dell SD, Sagel SD, Milla C, Zariwala MA, Pittman JE, Shapiro AJ, Carson JL, Krischer JP, Hazucha MJ, Cooper ML, Knowles MR, et al. Clinical features of childhood primary ciliary dyskinesia by genotype and ultrastructural phenotype. American Journal of Respiratory and Critical Care Medicine. 191: 316-24. PMID 25493340 DOI: 10.1164/Rccm.201409-1672Oc |
0.506 |
|
| 2015 |
Alpern AN, Brumback LC, Ratjen F, Rosenfeld M, Davis SD, Quittner AL. Initial evaluation of the Parent Cystic Fibrosis Questionnaire--Revised (CFQ-R) in infants and young children. Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society. 14: 403-11. PMID 25443473 DOI: 10.1016/J.Jcf.2014.11.002 |
0.592 |
|
| 2015 |
Zemanick ET, Emerson J, Thompson V, McNamara S, Morgan W, Gibson RL, Rosenfeld M. Clinical outcomes after initial pseudomonas acquisition in cystic fibrosis. Pediatric Pulmonology. 50: 42-8. PMID 24644274 DOI: 10.1002/Ppul.23036 |
0.392 |
|
| 2015 |
Davies J, Cunningham S, Southern K, Robertson S, Green Y, Cooke J, Higgins M, Rosenfeld M. S18 Ivacaftor treatment in preschool children with cystic fibrosis and a CFTR gating mutation: extended evaluation: Abstract S18 Table 1 Thorax. 70: A14-A15. DOI: 10.1136/Thoraxjnl-2015-207770.24 |
0.398 |
|
| 2015 |
Rosenfeld M, Robertson S, Green Y, Cooke J, Lawal A, Davies J. WS01.5 An open-label study of the safety, pharmacokinetics, and pharmacodynamics of ivacaftor in patients aged 2 to 5 years with cystic fibrosis and a CFTR gating mutation: The KIWI study Journal of Cystic Fibrosis. 14: S2. DOI: 10.1016/S1569-1993(15)30005-9 |
0.38 |
|
| 2014 |
Mogayzel PJ, Naureckas ET, Robinson KA, Brady C, Guill M, Lahiri T, Lubsch L, Matsui J, Oermann CM, Ratjen F, Rosenfeld M, Simon RH, Hazle L, Sabadosa K, Marshall BC, et al. Cystic Fibrosis Foundation pulmonary guideline. pharmacologic approaches to prevention and eradication of initial Pseudomonas aeruginosa infection. Annals of the American Thoracic Society. 11: 1640-50. PMID 25549030 DOI: 10.1513/Annalsats.201404-166Oc |
0.417 |
|
| 2014 |
Zemanick ET, Hoffman L, Rosenfeld M. Narrowing in on early cystic fibrosis lung disease. American Journal of Respiratory and Critical Care Medicine. 190: 1082-4. PMID 25398104 DOI: 10.1164/Rccm.201410-1929Ed |
0.42 |
|
| 2014 |
Shapiro AJ, Weck KE, Chao KC, Rosenfeld M, Nygren AO, Knowles MR, Leigh MW, Zariwala MA. Cri du chat syndrome and primary ciliary dyskinesia: a common genetic cause on chromosome 5p. The Journal of Pediatrics. 165: 858-61. PMID 25066065 DOI: 10.1016/J.Jpeds.2014.06.048 |
0.309 |
|
| 2014 |
Daines C, VanDeVanter D, Khan U, Emerson J, Heltshe S, McNamara S, Anstead M, Langkamp M, Doring G, Ratjen F, Ramsey B, Gibson RL, Morgan W, Rosenfeld M. Serology as a diagnostic tool for predicting initialPseudomonas aeruginosa acquisition in children with cystic fibrosis. Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society. 13: 542-9. PMID 25027419 DOI: 10.1016/J.Jcf.2014.06.005 |
0.437 |
|
| 2014 |
Mayer-Hamblett N, Rosenfeld M, Gibson RL, Ramsey BW, Kulasekara HD, Retsch-Bogart GZ, Morgan W, Wolter DJ, Pope CE, Houston LS, Kulasekara BR, Khan U, Burns JL, Miller SI, Hoffman LR. Pseudomonas aeruginosa in vitro phenotypes distinguish cystic fibrosis infection stages and outcomes. American Journal of Respiratory and Critical Care Medicine. 190: 289-97. PMID 24937177 DOI: 10.1164/Rccm.201404-0681Oc |
0.382 |
|
| 2014 |
Psoter KJ, Rosenfeld M, De Roos AJ, Mayer JD, Wakefield J. Differential geographical risk of initial Pseudomonas aeruginosa acquisition in young US children with cystic fibrosis. American Journal of Epidemiology. 179: 1503-13. PMID 24875373 DOI: 10.1093/Aje/Kwu077 |
0.374 |
|
| 2014 |
Mayer-Hamblett N, Ramsey BW, Kulasekara HD, Wolter DJ, Houston LS, Pope CE, Kulasekara BR, Armbruster CR, Burns JL, Retsch-Bogart G, Rosenfeld M, Gibson RL, Miller SI, Khan U, Hoffman LR. Pseudomonas aeruginosa phenotypes associated with eradication failure in children with cystic fibrosis. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 59: 624-31. PMID 24863401 DOI: 10.1093/Cid/Ciu385 |
0.45 |
|
| 2014 |
Brumback LC, Baines A, Ratjen F, Davis SD, Daniel SL, Quittner AL, Rosenfeld M. Pulmonary exacerbations and parent-reported outcomes in children <6 years with cystic fibrosis. Pediatric Pulmonology. PMID 24777957 DOI: 10.1002/Ppul.23056 |
0.585 |
|
| 2014 |
Shapiro AJ, Davis SD, Ferkol T, Dell SD, Rosenfeld M, Olivier KN, Sagel SD, Milla C, Zariwala MA, Wolf W, Carson JL, Hazucha MJ, Burns K, Robinson B, Knowles MR, et al. Laterality defects other than situs inversus totalis in primary ciliary dyskinesia: insights into situs ambiguus and heterotaxy. Chest. 146: 1176-86. PMID 24577564 DOI: 10.1378/Chest.13-1704 |
0.472 |
|
| 2014 |
Knowles MR, Ostrowski LE, Leigh MW, Sears PR, Davis SD, Wolf WE, Hazucha MJ, Carson JL, Olivier KN, Sagel SD, Rosenfeld M, Ferkol TW, Dell SD, Milla CE, Randell SH, et al. Mutations in RSPH1 cause primary ciliary dyskinesia with a unique clinical and ciliary phenotype. American Journal of Respiratory and Critical Care Medicine. 189: 707-17. PMID 24568568 DOI: 10.1164/Rccm.201311-2047Oc |
0.513 |
|
| 2014 |
Stanojevic S, Stocks J, Bountziouka V, Aurora P, Kirkby J, Bourke S, Carr SB, Gunn E, Prasad A, Rosenfeld M, Bilton D. The impact of switching to the new global lung function initiative equations on spirometry results in the UK CF registry. Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society. 13: 319-27. PMID 24332996 DOI: 10.1016/J.Jcf.2013.11.006 |
0.334 |
|
| 2014 |
Ren CL, Konstan MW, Rosenfeld M, Pasta DJ, Millar SJ, Morgan WJ. Early childhood wheezing is associated with lower lung function in cystic fibrosis. Pediatric Pulmonology. 49: 745-50. PMID 24123917 DOI: 10.1002/Ppul.22894 |
0.461 |
|
| 2014 |
Peterson-Carmichael SL, Rosenfeld M, Ascher SB, Hornik CP, Arets HG, Davis SD, Hall GL. Survey of clinical infant lung function testing practices. Pediatric Pulmonology. 49: 126-31. PMID 23765632 DOI: 10.1002/Ppul.22807 |
0.545 |
|
| 2013 |
Austin-Tse C, Halbritter J, Zariwala MA, Gilberti RM, Gee HY, Hellman N, Pathak N, Liu Y, Panizzi JR, Patel-King RS, Tritschler D, Bower R, O'Toole E, Porath JD, Hurd TW, ... ... Rosenfeld M, et al. Zebrafish Ciliopathy Screen Plus Human Mutational Analysis Identifies C21orf59 and CCDC65 Defects as Causing Primary Ciliary Dyskinesia. American Journal of Human Genetics. 93: 672-86. PMID 24094744 DOI: 10.1016/J.Ajhg.2013.08.015 |
0.502 |
|
| 2013 |
Leigh MW, Hazucha MJ, Chawla KK, Baker BR, Shapiro AJ, Brown DE, Lavange LM, Horton BJ, Qaqish B, Carson JL, Davis SD, Dell SD, Ferkol TW, Atkinson JJ, Olivier KN, ... ... Rosenfeld M, et al. Standardizing nasal nitric oxide measurement as a test for primary ciliary dyskinesia. Annals of the American Thoracic Society. 10: 574-81. PMID 24024753 DOI: 10.1513/Annalsats.201305-110Oc |
0.476 |
|
| 2013 |
Mayer-Hamblett N, Rosenfeld M, Treggiari MM, Konstan MW, Retsch-Bogart G, Morgan W, Wagener J, Gibson RL, Khan U, Emerson J, Thompson V, Elkin EP, Ramsey BW. Standard care versus protocol based therapy for new onset Pseudomonas aeruginosa in cystic fibrosis. Pediatric Pulmonology. 48: 943-53. PMID 23818295 DOI: 10.1002/Ppul.22693 |
0.362 |
|
| 2013 |
Psoter KJ, De Roos AJ, Wakefield J, Mayer J, Rosenfeld M. Season is associated with Pseudomonas aeruginosa acquisition in young children with cystic fibrosis. Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases. 19: E483-9. PMID 23795938 DOI: 10.1111/1469-0691.12272 |
0.408 |
|
| 2013 |
Mayer-Hamblett N, Saiman L, Lands LC, Anstead M, Rosenfeld M, Kloster M, Fisher L, Ratjen F. Impact of acute antibiotic therapy on the pulmonary exacerbation endpoint in cystic fibrosis clinical trials. Contemporary Clinical Trials. 36: 99-105. PMID 23770109 DOI: 10.1016/J.Cct.2013.06.004 |
0.394 |
|
| 2013 |
Subbarao P, Stanojevic S, Brown M, Jensen R, Rosenfeld M, Davis S, Brumback L, Gustafsson P, Ratjen F. Lung clearance index as an outcome measure for clinical trials in young children with cystic fibrosis. A pilot study using inhaled hypertonic saline. American Journal of Respiratory and Critical Care Medicine. 188: 456-60. PMID 23742699 DOI: 10.1164/Rccm.201302-0219Oc |
0.632 |
|
| 2013 |
Rosenfeld M, Farrell PM, Kloster M, Swanson JO, Vu T, Brumback L, Acton JD, Castile RG, Colin AA, Conrad CK, Hart MA, Kerby GS, Hiatt PW, Mogayzel PJ, Johnson RC, et al. Association of lung function, chest radiographs and clinical features in infants with cystic fibrosis. The European Respiratory Journal. 42: 1545-52. PMID 23722613 DOI: 10.1183/09031936.00138412 |
0.605 |
|
| 2013 |
Rosenfeld M, Allen J, Arets BH, Aurora P, Beydon N, Calogero C, Castile RG, Davis SD, Fuchs S, Gappa M, Gustaffson PM, Hall GL, Jones MH, Kirkby JC, Kraemer R, et al. An official American Thoracic Society workshop report: optimal lung function tests for monitoring cystic fibrosis, bronchopulmonary dysplasia, and recurrent wheezing in children less than 6 years of age. Annals of the American Thoracic Society. 10: S1-S11. PMID 23607855 DOI: 10.1513/Annalsats.201301-017St |
0.63 |
|
| 2013 |
Stick S, Tiddens H, Aurora P, Gustafsson P, Ranganathan S, Robinson P, Rosenfeld M, Sly P, Ratjen F. Early intervention studies in infants and preschool children with cystic fibrosis: are we ready? The European Respiratory Journal. 42: 527-38. PMID 23520316 DOI: 10.1183/09031936.00108212 |
0.478 |
|
| 2013 |
Bakker EM, Borsboom GJ, van der Wiel-Kooij EC, Caudri D, Rosenfeld M, Tiddens HA. Small airway involvement in cystic fibrosis lung disease: routine spirometry as an early and sensitive marker. Pediatric Pulmonology. 48: 1081-8. PMID 23401260 DOI: 10.1002/Ppul.22777 |
0.463 |
|
| 2013 |
Byrnes CA, Vidmar S, Cheney JL, Carlin JB, Armstrong DS, Cooper PJ, Grimwood K, Moodie M, Robertson CF, Rosenfeld M, Tiddens HA, Wainwright CE. Prospective evaluation of respiratory exacerbations in children with cystic fibrosis from newborn screening to 5 years of age. Thorax. 68: 643-51. PMID 23345574 DOI: 10.1136/Thoraxjnl-2012-202342 |
0.474 |
|
| 2013 |
Knowles MR, Leigh MW, Ostrowski LE, Huang L, Carson JL, Hazucha MJ, Yin W, Berg JS, Davis SD, Dell SD, Ferkol TW, Rosenfeld M, Sagel SD, Milla CE, Olivier KN, et al. Exome sequencing identifies mutations in CCDC114 as a cause of primary ciliary dyskinesia. American Journal of Human Genetics. 92: 99-106. PMID 23261302 DOI: 10.1016/J.Ajhg.2012.11.003 |
0.5 |
|
| 2013 |
Loeve M, Krestin GP, Rosenfeld M, de Bruijne M, Stick SM, Tiddens HA. Chest computed tomography: a validated surrogate endpoint of cystic fibrosis lung disease? The European Respiratory Journal. 42: 844-57. PMID 23258780 DOI: 10.1183/09031936.00051512 |
0.457 |
|
| 2013 |
Anstead M, Heltshe SL, Khan U, Barbieri JT, Langkamp M, Döring G, Dharia S, Gibson RL, Treggiari MM, Lymp J, Rosenfeld M, Ramsey B. Pseudomonas aeruginosa serology and risk for re-isolation in the EPIC trial. Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society. 12: 147-53. PMID 22944725 DOI: 10.1016/J.Jcf.2012.08.001 |
0.337 |
|
| 2013 |
Brumback LC, Davis SD, Kerby GS, Kloster M, Johnson R, Castile R, Hiatt PW, Hart M, Rosenfeld M. Lung function from infancy to preschool in a cohort of children with cystic fibrosis. The European Respiratory Journal. 41: 60-6. PMID 22653767 DOI: 10.1183/09031936.00021612 |
0.617 |
|
| 2013 |
Ruddy J, Emerson J, Moss R, Genatossio A, McNamara S, Burns JL, Anderson G, Rosenfeld M. Sputum tobramycin concentrations in cystic fibrosis patients with repeated administration of inhaled tobramycin. Journal of Aerosol Medicine and Pulmonary Drug Delivery. 26: 69-75. PMID 22620494 DOI: 10.1089/Jamp.2011.0942 |
0.307 |
|
| 2013 |
Rosenfeld M, Ratjen F, Brumback L, Daniel S, Rowbotham R, Mc Namara S, Johnson R, Kronmal R, Davis SD. Inhaled Hypertonic Saline in Infants and Children Younger Than 6 Years With Cystic Fibrosis (ISIS) Survey of Anesthesiology. 57: 30. DOI: 10.1097/Sa.0B013E31827F338C |
0.582 |
|
| 2013 |
Tepper L, Caudri D, Rosenfeld M, Tiddens H. 199 Early predictors of bronchiectasis and trapped air severity in cystic fibrosis Journal of Cystic Fibrosis. 12: S99. DOI: 10.1016/S1569-1993(13)60340-9 |
0.365 |
|
| 2012 |
Rosenfeld M, Ratjen F, Brumback L, Daniel S, Rowbotham R, McNamara S, Johnson R, Kronmal R, Davis SD. Inhaled hypertonic saline in infants and children younger than 6 years with cystic fibrosis: the ISIS randomized controlled trial. Jama. 307: 2269-77. PMID 22610452 DOI: 10.1001/Jama.2012.5214 |
0.596 |
|
| 2012 |
Rosenfeld M, Emerson J, McNamara S, Thompson V, Ramsey BW, Morgan W, Gibson RL. Risk factors for age at initial Pseudomonas acquisition in the cystic fibrosis epic observational cohort. Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society. 11: 446-53. PMID 22554417 DOI: 10.1016/J.Jcf.2012.04.003 |
0.36 |
|
| 2012 |
Rosenfeld M, Bernardo-Ocampo C, Emerson J, Genatossio A, Burns J, Gibson R. Prevalence of cystic fibrosis pathogens in the oropharynx of healthy children and implications for cystic fibrosis care. Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society. 11: 456-7. PMID 22551927 DOI: 10.1016/J.Jcf.2012.04.004 |
0.398 |
|
| 2012 |
Knowles MR, Leigh MW, Carson JL, Davis SD, Dell SD, Ferkol TW, Olivier KN, Sagel SD, Rosenfeld M, Burns KA, Minnix SL, Armstrong MC, Lori A, Hazucha MJ, Loges NT, et al. Mutations of DNAH11 in patients with primary ciliary dyskinesia with normal ciliary ultrastructure. Thorax. 67: 433-41. PMID 22184204 DOI: 10.1136/Thoraxjnl-2011-200301 |
0.521 |
|
| 2012 |
Ren CL, Rosenfeld M, Mayer OH, Davis SD, Kloster M, Castile RG, Hiatt PW, Hart M, Johnson R, Jones P, Brumback LC, Kerby GS. Analysis of the associations between lung function and clinical features in preschool children with cystic fibrosis. Pediatric Pulmonology. 47: 574-81. PMID 22081584 DOI: 10.1002/Ppul.21590 |
0.612 |
|
| 2012 |
Kerby GS, Rosenfeld M, Ren CL, Mayer OH, Brumback L, Castile R, Hart MA, Hiatt P, Kloster M, Johnson R, Jones P, Davis SD. Lung function distinguishes preschool children with CF from healthy controls in a multi-center setting. Pediatric Pulmonology. 47: 597-605. PMID 22081559 DOI: 10.1002/Ppul.21589 |
0.62 |
|
| 2012 |
Mayer-Hamblett N, Kronmal RA, Gibson RL, Rosenfeld M, Retsch-Bogart G, Treggiari MM, Burns JL, Khan U, Ramsey BW. Initial Pseudomonas aeruginosa treatment failure is associated with exacerbations in cystic fibrosis. Pediatric Pulmonology. 47: 125-34. PMID 21830317 DOI: 10.1002/Ppul.21525 |
0.391 |
|
| 2012 |
Ratjen F, Rosenfeld M, Brumback L, Daniel S, Rowbotham R, Kronmal R, Davis S. WS22.1 Efficacy of hypertonic saline in infants and young children: the ISIS study Journal of Cystic Fibrosis. 11: S50. DOI: 10.1016/S1569-1993(12)60157-X |
0.525 |
|
| 2011 |
Ranganathan SC, Davis SD, Rosenfeld M. Monitoring of Structure and Function in Early Cystic Fibrosis Lung Disease. Pediatric Allergy, Immunology, and Pulmonology. 24: 133-137. PMID 35927871 DOI: 10.1089/ped.2011.0079 |
0.597 |
|
| 2011 |
Treggiari MM, Retsch-Bogart G, Mayer-Hamblett N, Khan U, Kulich M, Kronmal R, Williams J, Hiatt P, Gibson RL, Spencer T, Orenstein D, Chatfield BA, Froh DK, Burns JL, Rosenfeld M, et al. Comparative efficacy and safety of 4 randomized regimens to treat early Pseudomonas aeruginosa infection in children with cystic fibrosis. Archives of Pediatrics & Adolescent Medicine. 165: 847-56. PMID 21893650 DOI: 10.1001/Archpediatrics.2011.136 |
0.354 |
|
| 2011 |
Rosenfeld M, Davis S, Brumback L, Daniel S, Rowbotham R, Johnson R, McNamara S, Jensen R, Barlow C, Ratjen F. Inhaled hypertonic saline in infants and toddlers with cystic fibrosis: short-term tolerability, adherence, and safety. Pediatric Pulmonology. 46: 666-71. PMID 21365779 DOI: 10.1002/Ppul.21425 |
0.572 |
|
| 2011 |
Olin JT, Burns K, Carson JL, Metjian H, Atkinson JJ, Davis SD, Dell SD, Ferkol TW, Milla CE, Olivier KN, Rosenfeld M, Baker B, Leigh MW, Knowles MR, Sagel SD, et al. Diagnostic yield of nasal scrape biopsies in primary ciliary dyskinesia: a multicenter experience. Pediatric Pulmonology. 46: 483-8. PMID 21284095 DOI: 10.1002/Ppul.21402 |
0.534 |
|
| 2011 |
Loeve M, Gerbrands K, Hop WC, Rosenfeld M, Hartmann IC, Tiddens HA. Bronchiectasis and pulmonary exacerbations in children and young adults with cystic fibrosis. Chest. 140: 178-85. PMID 21148242 DOI: 10.1378/Chest.10-1152 |
0.343 |
|
| 2011 |
Sanders DB, Bittner RC, Rosenfeld M, Redding GJ, Goss CH. Pulmonary exacerbations are associated with subsequent FEV1 decline in both adults and children with cystic fibrosis. Pediatric Pulmonology. 46: 393-400. PMID 20967845 DOI: 10.1002/Ppul.21374 |
0.462 |
|
| 2011 |
Ranganathan SC, Davis SD, Rosenfeld M. Monitoring of structure and function in early cystic fibrosis lung disease Pediatric, Allergy, Immunology, and Pulmonology. 24: 133-137. DOI: 10.1089/Ped.2011.0079 |
0.639 |
|
| 2011 |
Pittman JE, Rosenfeld M. Appropriate pediatric spirometry reference equations and interpretation Pediatric, Allergy, Immunology, and Pulmonology. 24: 63-68. DOI: 10.1089/Ped.2011.0075 |
0.317 |
|
| 2010 |
Davis SD, Rosenfeld M, Kerby GS, Brumback L, Kloster MH, Acton JD, Colin AA, Conrad CK, Hart MA, Hiatt PW, Mogayzel PJ, Johnson RC, Wilcox SL, Castile RG. Multicenter evaluation of infant lung function tests as cystic fibrosis clinical trial endpoints. American Journal of Respiratory and Critical Care Medicine. 182: 1387-97. PMID 20622043 DOI: 10.1164/Rccm.200908-1236Oc |
0.599 |
|
| 2010 |
Rosenfeld M, Emerson J, McNamara S, Joubran K, Retsch-Bogart G, Graff GR, Gutierrez HH, Kanga JF, Lahiri T, Noyes B, Ramsey B, Ren CL, Schechter M, Morgan W, Gibson RL, et al. Baseline characteristics and factors associated with nutritional and pulmonary status at enrollment in the cystic fibrosis EPIC observational cohort. Pediatric Pulmonology. 45: 934-44. PMID 20597081 DOI: 10.1002/Ppul.21279 |
0.474 |
|
| 2010 |
DiBlasi RM, Crotwell D, Geiduscheck JM, Richardson P, Smith A, Salyer JW, Rosenfeld M. Therapeutic bilateral lung lavage in a child with pulmonary alveolar proteinosis. Pediatric Critical Care Medicine : a Journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies. 11: e28-31. PMID 20453607 DOI: 10.1097/Pcc.0B013E3181B809D6 |
0.413 |
|
| 2010 |
Sanders DB, Hoffman LR, Emerson J, Gibson RL, Rosenfeld M, Redding GJ, Goss CH. Return of FEV1 after pulmonary exacerbation in children with cystic fibrosis. Pediatric Pulmonology. 45: 127-34. PMID 20054859 DOI: 10.1002/Ppul.21117 |
0.456 |
|
| 2010 |
Sanders DB, Hoffman LR, Emerson J, Gibson RL, Rosenfeld M, Redding GJ, Goss CH. Return of FEV1 after pulmonary exacerbation in children with cystic fibrosis (Pediatric Pulmonology (2010) 45, 2 (127-134) DOI: 10.1002/ppul.21117) Pediatric Pulmonology. 45: 521-522. DOI: 10.1002/Ppul.21249 |
0.444 |
|
| 2009 |
Borowitz D, Robinson KA, Rosenfeld M, Davis SD, Sabadosa KA, Spear SL, Michel SH, Parad RB, White TB, Farrell PM, Marshall BC, Accurso FJ. Cystic Fibrosis Foundation evidence-based guidelines for management of infants with cystic fibrosis. The Journal of Pediatrics. 155: S73-93. PMID 19914445 DOI: 10.1016/J.Jpeds.2009.09.001 |
0.71 |
|
| 2009 |
Borowitz D, Parad RB, Sharp JK, Sabadosa KA, Robinson KA, Rock MJ, Farrell PM, Sontag MK, Rosenfeld M, Davis SD, Marshall BC, Accurso FJ. Cystic Fibrosis Foundation practice guidelines for the management of infants with cystic fibrosis transmembrane conductance regulator-related metabolic syndrome during the first two years of life and beyond. The Journal of Pediatrics. 155: S106-16. PMID 19914443 DOI: 10.1016/J.Jpeds.2009.09.003 |
0.717 |
|
| 2009 |
Treggiari MM, Rosenfeld M, Mayer-Hamblett N, Retsch-Bogart G, Gibson RL, Williams J, Emerson J, Kronmal RA, Ramsey BW. Early anti-pseudomonal acquisition in young patients with cystic fibrosis: rationale and design of the EPIC clinical trial and observational study'. Contemporary Clinical Trials. 30: 256-68. PMID 19470318 DOI: 10.1016/J.Cct.2009.01.003 |
0.451 |
|
| 2009 |
Loeve M, Gerbrands K, Hop W, Rosenfeld M, Tiddens H. Bronchiectasis (BE) on CT is a strong predictor of respiratory tract exacerbations in children with CF Journal of Cystic Fibrosis. 8: S68. DOI: 10.1016/S1569-1993(09)60269-1 |
0.384 |
|
| 2008 |
Sanders DB, Rosenfeld M, Mayer-Hamblett N, Stamey D, Redding GJ. Reproducibility of spirometry during cystic fibrosis pulmonary exacerbations. Pediatric Pulmonology. 43: 1142-6. PMID 18846562 DOI: 10.1002/Ppul.20924 |
0.403 |
|
| 2007 |
Veenstra DL, Harris J, Gibson RL, Rosenfeld M, Burke W, Watts C. Pharmacogenomic testing to prevent aminoglycoside-induced hearing loss in cystic fibrosis patients: potential impact on clinical, patient, and economic outcomes. Genetics in Medicine : Official Journal of the American College of Medical Genetics. 9: 695-704. PMID 18073583 DOI: 10.1097/Gim.0B013E318156Dd07 |
0.37 |
|
| 2007 |
Davis SD, Brody AS, Emond MJ, Brumback LC, Rosenfeld M. Endpoints for clinical trials in young children with cystic fibrosis. Proceedings of the American Thoracic Society. 4: 418-30. PMID 17652509 DOI: 10.1513/pats.200703-041BR |
0.606 |
|
| 2007 |
Treggiari MM, Rosenfeld M, Retsch-Bogart G, Gibson R, Ramsey B. Approach to eradication of initial Pseudomonas aeruginosa infection in children with cystic fibrosis. Pediatric Pulmonology. 42: 751-6. PMID 17647287 DOI: 10.1002/Ppul.20665 |
0.353 |
|
| 2007 |
Comeau AM, Accurso FJ, White TB, Campbell PW, Hoffman G, Parad RB, Wilfond BS, Rosenfeld M, Sontag MK, Massie J, Farrell PM, O'Sullivan BP. Guidelines for implementation of cystic fibrosis newborn screening programs: Cystic Fibrosis Foundation workshop report. Pediatrics. 119: e495-518. PMID 17272609 DOI: 10.1542/Peds.2006-1993 |
0.618 |
|
| 2006 |
Grosse SD, Rosenfeld M, Devine OJ, Lai HJ, Farrell PM. Potential impact of newborn screening for cystic fibrosis on child survival: a systematic review and analysis. The Journal of Pediatrics. 149: 362-6. PMID 16939748 DOI: 10.1016/J.Jpeds.2006.04.059 |
0.36 |
|
| 2006 |
Ferkol T, Rosenfeld M, Milla CE. Cystic fibrosis pulmonary exacerbations. The Journal of Pediatrics. 148: 259-64. PMID 16492439 DOI: 10.1016/J.Jpeds.2005.10.019 |
0.422 |
|
| 2005 |
Rosenfeld M. Overview of published evidence on outcomes with early diagnosis from large US observational studies. The Journal of Pediatrics. 147: S11-4. PMID 16202774 DOI: 10.1016/J.Jpeds.2005.08.010 |
0.444 |
|
| 2005 |
Debley JS, Carter ER, Gibson RL, Rosenfeld M, Redding GJ. The prevalence of ibuprofen-sensitive asthma in children: a randomized controlled bronchoprovocation challenge study. The Journal of Pediatrics. 147: 233-8. PMID 16126056 DOI: 10.1016/J.Jpeds.2005.03.055 |
0.309 |
|
| 2005 |
Kulich M, Rosenfeld M, Campbell J, Kronmal R, Gibson RL, Goss CH, Ramsey B. Disease-specific reference equations for lung function in patients with cystic fibrosis. American Journal of Respiratory and Critical Care Medicine. 172: 885-91. PMID 15976373 DOI: 10.1164/Rccm.200410-1335Oc |
0.456 |
|
| 2004 |
Goss CH, Rosenfeld M. Update on cystic fibrosis epidemiology. Current Opinion in Pulmonary Medicine. 10: 510-4. PMID 15510059 DOI: 10.1097/01.Mcp.0000138994.46519.72 |
0.402 |
|
| 2003 |
Rosenfeld M, Ramsey BW, Gibson RL. Pseudomonas acquisition in young patients with cystic fibrosis: pathophysiology, diagnosis, and management. Current Opinion in Pulmonary Medicine. 9: 492-7. PMID 14534401 DOI: 10.1097/00063198-200311000-00008 |
0.388 |
|
| 2003 |
Kulich M, Rosenfeld M, Goss CH, Wilmott R. Improved survival among young patients with cystic fibrosis. The Journal of Pediatrics. 142: 631-6. PMID 12838190 DOI: 10.1067/Mpd.2003.197 |
0.325 |
|
| 2003 |
Gibson RL, Emerson J, McNamara S, Burns JL, Rosenfeld M, Yunker A, Hamblett N, Accurso F, Dovey M, Hiatt P, Konstan MW, Moss R, Retsch-Bogart G, Wagener J, Waltz D, et al. Significant microbiological effect of inhaled tobramycin in young children with cystic fibrosis. American Journal of Respiratory and Critical Care Medicine. 167: 841-9. PMID 12480612 DOI: 10.1164/Rccm.200208-855Oc |
0.385 |
|
| 2002 |
Mayer-Hamblett N, Rosenfeld M, Emerson J, Goss CH, Aitken ML. Developing cystic fibrosis lung transplant referral criteria using predictors of 2-year mortality. American Journal of Respiratory and Critical Care Medicine. 166: 1550-5. PMID 12406843 DOI: 10.1164/Rccm.200202-087Oc |
0.408 |
|
| 2002 |
Emerson J, Rosenfeld M, McNamara S, Ramsey B, Gibson RL. Pseudomonas aeruginosa and other predictors of mortality and morbidity in young children with cystic fibrosis. Pediatric Pulmonology. 34: 91-100. PMID 12112774 DOI: 10.1002/Ppul.10127 |
0.404 |
|
| 2001 |
Rosenfeld M, Joy P, Nguyen CD, Krzewinski J, Burns JL. Cleaning home nebulizers used by patients with cystic fibrosis: Is rinsing with tap water enough? Journal of Hospital Infection. 49: 229-230. PMID 11716644 DOI: 10.1053/Jhin.2001.1083 |
0.315 |
|
| 2001 |
Rosenfeld M, Gibson RL, McNamara S, Emerson J, Burns JL, Castile R, Hiatt P, McCoy K, Wilson CB, Inglis A, Smith A, Martin TR, Ramsey BW. Early pulmonary infection, inflammation, and clinical outcomes in infants with cystic fibrosis. Pediatric Pulmonology. 32: 356-66. PMID 11596160 DOI: 10.1002/Ppul.1144 |
0.46 |
|
| 2001 |
Rosenfeld M, Emerson J, Williams-Warren J, Pepe M, Smith A, Montgomery AB, Ramsey B. Defining a pulmonary exacerbation in cystic fibrosis. The Journal of Pediatrics. 139: 359-65. PMID 11562614 DOI: 10.1067/Mpd.2001.117288 |
0.413 |
|
| 2001 |
Rosenfeld M, Pepe MS, Longton G, Emerson J, Fitzsimmons S, Morgan W. Effect of choice of reference equation on analysis of pulmonary function in cystic fibrosis patients Pediatric Pulmonology. 31: 227-237. PMID 11276136 DOI: 10.1002/Ppul.1033 |
0.362 |
|
| 2001 |
Burns JL, Gibson RL, McNamara S, Yim D, Emerson J, Rosenfeld M, Hiatt P, McCoy K, Castile R, Smith AL, Ramsey BW. Longitudinal assessment of Pseudomonas aeruginosa in young children with cystic fibrosis. The Journal of Infectious Diseases. 183: 444-52. PMID 11133376 DOI: 10.1086/318075 |
0.432 |
|
| 1999 |
Rosenfeld M, Emerson J, Accurso F, Armstrong D, Castile R, Grimwood K, Hiatt P, McCoy K, McNamara S, Ramsey B, Wagener J. Diagnostic accuracy of oropharyngeal cultures in infants and young children with cystic fibrosis. Pediatric Pulmonology. 28: 321-8. PMID 10536062 DOI: 10.1002/(Sici)1099-0496(199911)28:5<321::Aid-Ppul3>3.0.Co;2-V |
0.398 |
|
| 1999 |
Rosenfeld M, Casey S, Pepe M, Ramsey BW. Nutritional effects of long-term gastrostomy feedings in children with cystic fibrosis Journal of the American Dietetic Association. 99: 191-194. PMID 9972186 DOI: 10.1016/S0002-8223(99)00046-2 |
0.366 |
|
| 1998 |
Rosenfeld M, Emerson J, Astley S, Joy P, Williams-Warren J, Standaert TA, Yim DL, Crist D, Thykkuttathil MJ, Torrence M, FitzSimmons S, Ramsey B. Home nebulizer use among patients with cystic fibrosis Journal of Pediatrics. 132: 125-131. PMID 9470013 DOI: 10.1016/S0022-3476(98)70497-4 |
0.35 |
|
| 1997 |
Rosenfeld M, Davis R, FitzSimmons S, Pepe M, Ramsey B. Gender Gap in Cystic Fibrosis Mortality American Journal of Epidemiology. 145: 794-803. PMID 9143209 DOI: 10.1093/Oxfordjournals.Aje.A009172 |
0.324 |
|
| Show low-probability matches. |
